KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Hologic (HOLX) EBT (2016 - 2025)

Hologic (HOLX) has disclosed EBT for 17 consecutive years, with $229.7 million as the latest value for Q4 2025.

  • Quarterly EBT fell 7.19% to $229.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $663.4 million through Dec 2025, down 27.99% year-over-year, with the annual reading at $681.2 million for FY2025, 21.26% down from the prior year.
  • EBT hit $229.7 million in Q4 2025 for Hologic, up from $227.2 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $780.5 million in Q1 2021 to a low of -$28.5 million in Q1 2025.
  • Historically, EBT has averaged $278.4 million across 5 years, with a median of $237.0 million in 2022.
  • Biggest five-year swings in EBT: surged 1889.26% in 2024 and later tumbled 113.48% in 2025.
  • Year by year, EBT stood at $621.9 million in 2021, then tumbled by 61.55% to $239.1 million in 2022, then dropped by 19.99% to $191.3 million in 2023, then grew by 29.38% to $247.5 million in 2024, then dropped by 7.19% to $229.7 million in 2025.
  • Business Quant data shows EBT for HOLX at $229.7 million in Q4 2025, $227.2 million in Q3 2025, and $235.0 million in Q2 2025.